MMP9 and ovarian cancer: CircATRNL1 absorbs miR-378, activates Smad4, and further decreases the activities of Akt, Cyclin D1, MMP2 and MMP9, thereby inhibiting proliferation, angiogenesis and metastasis of ovarian cancer cells [31].